Neurogene Inc.
Q4 2023 13F Holders
Symbol
NGNE
CUSIP
64135M105
Type
Equity
Class
COM
Num filers
36
Total reported value, excl. options
$179M
Compare 2023 Q4 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type